Stocks and Investing
Stocks and Investing
Wed, November 15, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, November 14, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Kristen Stewart Upgraded (ZBH) to Strong Buy on, Nov 14th, 2017
Kristen Stewart of Deutsche Bank, Upgraded "Zimmer Biomet Holdings, Inc." (ZBH) to Strong Buy on, Nov 14th, 2017.
Kristen has made no other calls on ZBH in the last 4 months.
There are 6 other peers that have a rating on ZBH. Out of the 6 peers that are also analyzing ZBH, 2 agree with Kristen's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew O'Brien of "Piper Sandler" Downgraded from Buy to Hold on, Thursday, November 2nd, 2017
- Kyle Rose of "Canaccord Genuity" Downgraded from Strong Buy to Hold on, Friday, July 28th, 2017
These are the ratings of the 4 analyists that currently disagree with Kristen
- David Lewis of "Morgan Stanley" Maintained at Buy with Decreased Target to $136 on, Thursday, November 2nd, 2017
- Joanne Wuensch of "BMO Capital" Maintained at Buy with Decreased Target to $135 on, Thursday, November 2nd, 2017
- Jennie Tsai of "Gabelli & Co." Initiated at Strong Buy on, Thursday, August 24th, 2017
- Richard Newitter of "Leerink Swann" Maintained at Buy with Increased Target to $146 on, Friday, July 28th, 2017
Contributing Sources